Michael Weinstein’s AIDS Healthcare Foundation treats an enormous number of patients — and makes an enormous amount of money. Is that why so many activists distrust him?
3 hours ago | New York Times
It is astonishing that strong, albeit subtle, resistance for PrEP scale-up in Thailand comes from a few influential leaders of HIV NGOs. Small in number, these NGOs are vocal and influential. Their opinions are esteemed by government officials and fellow NGOs. The resistance is not stated in public. Most of the objections to PrEP I have heard from these individuals during backroom talks or various office meetings or private discussions. Concerns, doubts, or cautions against PrEP that are said in public were vague and ambivalent.
22 hours ago | AVAC
Critics say Mike Pence was slow to react as a festering blight, then HIV gripped Austin, Indiana. This tiny city off Interstate 65 is the epicenter of a medical disaster. Dr. Tom Frieden, former director of the U.S. Centers for Disease Control and Prevention, confirms Austin contains the largest drug-fueled HIV outbreak to hit rural America in recent history, and "the largest concentrated outbreak ever documented in the United States."
24 April 2017 | Kentucky Courier-Journal
This piece has generated a considerable amount of concern in the HIV community already as its content is completely at odds with current recommendations by the World Health Organisation and NICE which recognise that HIV pre-exposure prophylaxis (PrEP) is an important component of HIV prevention. Numerous studies have shown that PrEP is a highly clinically and cost-effective safe intervention which reduces the risk of becoming infected with HIV by around 90%.
24 April 2017 | BHIVA
Please read and share this letter signed by the European AIDS Treatment Group and the PrEP in Europe Initiative (PEI), a partnership of European prevention and policy NGOs. It requests Gilead Sciences to surrender their patent of Truvada® or otherwise make it possible for Truvada or generic equivalents of it to be offered at greatly reduced prices to all European health care systems so that it can be used as HIV pre-exposure prophylaxis (PrEP).
18 April 2017 | EATG / PrEP in Europe
The Scottish pathway to the PrEP policy decision has been very different to that of England.
13 April 2017 | Sociology Lens
Meet Tom, Dick and Harry. Sydney-based health promotion organization ACON’s current campaign singles out different men who “do it”, but who opt for different ways of protecting themselves. “We all have notions of what safe sex means, but we wanted to reflect actual behaviour among gay men and other men who have sex with men,” said ACON Chief Executive Officer Nicolas Parkhill.
05 April 2017 | UNAIDS
The new national strategic plan for HIV and TB is a plan that seems reasonable when considered in the abstract, but that risks falling apart when confronted by the realities of the public healthcare system and political context.
04 April 2017 | AllAfrica
In the plan are a set of bold and ambitious targets which include reducing new HIV infections from 270 000 to less than 100 000 per year, reducing new tuberculosis (TB) infections from 450 000 to less than 315 000 per year and reaching the 90–90–90 targets.
04 April 2017 | UNAIDS
In January 2017, the Ministry of Finance of the Russian Federation rejected a request to allocate $1.2 billion over four years for the response to HIV, citing “a lack of federal funds.” The Ministry of Health had asked for the funds in order to implement the National AIDS Strategy 2017-2020. The rejection of the funding request once again brought into question the ability and willingness of the Russian Federation to manage its serious HIV epidemic.
04 April 2017 | Global Fund Observer